Skip to content

ASSESSING THE EFFECTIVENESS OF A NEW ANTI-DIABETIC FORMULATION (DIAKURE)

A RANDOMISED, PROSPECTIVE SINGLE BLIND CLINICAL TRIAL OF ANTI DIABETIC POLYHERBAL FORMULATION [DiaKure]

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/06/005891
Enrollment
80
Registered
2015-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- DIABETIC

Interventions

Intervention1: Vetivera Zizanoidis
Hemidesmus Indicus
Strychnos Potatorum
Salacia Reticulata
Acasia Catechu
Holarhena Antidysenterica
Cassia Auriculata
Trigonella Gracun: 12 gm per day as a powder formulation mixed in hot water given twice a day in the morning and at bedtime after food.This regimen will be continued for 180 days. Control Intervention

Sponsors

RVS COLLEGE OF PHARMACEUTICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with type 2 diabetes mellitus. 2. Patient who are keeping up their regular follow-up visits. 3. Patients who are competent enough to consider informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who are very frail. 2. Patients in their gestational and lactating period. 3. Patients diagnosed with cardiac and psychiatric disorders. 4. Patients above and below the age group.

Design outcomes

Primary

MeasureTime frame
Blood sugar levels (both random and fasting)Timepoint: Once in 15 days.

Secondary

MeasureTime frame
Glycosylated Hemoglobin (HbA1c) BMITimepoint: Once in 60 days.

Countries

India

Contacts

Public ContactCS Kandasamy

RVS COLLEGE OF PHARMACEUTICAL SCIENCES

fly2johnny@gmail.com9894676716

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026